1. Home
  2. AFMD vs TKLF Comparison

AFMD vs TKLF Comparison

Compare AFMD & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • TKLF
  • Stock Information
  • Founded
  • AFMD 2000
  • TKLF 2006
  • Country
  • AFMD Germany
  • TKLF Japan
  • Employees
  • AFMD N/A
  • TKLF N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • TKLF Other Specialty Stores
  • Sector
  • AFMD Health Care
  • TKLF Consumer Discretionary
  • Exchange
  • AFMD Nasdaq
  • TKLF Nasdaq
  • Market Cap
  • AFMD 14.5M
  • TKLF 15.7M
  • IPO Year
  • AFMD 2014
  • TKLF 2022
  • Fundamental
  • Price
  • AFMD $0.72
  • TKLF $3.28
  • Analyst Decision
  • AFMD Strong Buy
  • TKLF
  • Analyst Count
  • AFMD 5
  • TKLF 0
  • Target Price
  • AFMD $13.50
  • TKLF N/A
  • AVG Volume (30 Days)
  • AFMD 86.2K
  • TKLF 12.4K
  • Earning Date
  • AFMD 04-08-2025
  • TKLF 12-18-2024
  • Dividend Yield
  • AFMD N/A
  • TKLF N/A
  • EPS Growth
  • AFMD N/A
  • TKLF N/A
  • EPS
  • AFMD N/A
  • TKLF 1.70
  • Revenue
  • AFMD $6,287,085.00
  • TKLF $219,520,631.00
  • Revenue This Year
  • AFMD N/A
  • TKLF N/A
  • Revenue Next Year
  • AFMD $225.65
  • TKLF N/A
  • P/E Ratio
  • AFMD N/A
  • TKLF $1.96
  • Revenue Growth
  • AFMD N/A
  • TKLF 32.02
  • 52 Week Low
  • AFMD $0.70
  • TKLF $2.00
  • 52 Week High
  • AFMD $8.95
  • TKLF $8.53
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 30.95
  • TKLF 45.08
  • Support Level
  • AFMD $0.85
  • TKLF $3.24
  • Resistance Level
  • AFMD $0.89
  • TKLF $3.38
  • Average True Range (ATR)
  • AFMD 0.05
  • TKLF 0.26
  • MACD
  • AFMD -0.01
  • TKLF 0.00
  • Stochastic Oscillator
  • AFMD 22.75
  • TKLF 30.43

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.

Share on Social Networks: